The latest data on osteoarthritis, joint health, and treatment trends in the United States.
Joint pain is one of the most common chronic health complaints in America, yet the scale of the problem is often underestimated. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), osteoarthritis affects over 32.5 million American adults — making it the most common form of arthritis and a leading cause of disability.
By age 65, more than half of all adults show X-ray evidence of osteoarthritis in at least one joint. The condition occurs when the protective cartilage that cushions the ends of bones wears down over time. Recent research has identified the ADAMTS-5 protein as a key driver of this cartilage degradation — a discovery that has opened new doors for targeted treatment approaches, including supplements like Joint Hero that specifically aim to address this protein.
Arthritis-related medical costs and lost earnings exceed $300 billion annually in the US. Over 1 million joint replacement surgeries are performed each year, with knee replacements accounting for the majority. The average cost of a knee replacement ranges from $30,000 to $50,000, making prevention and early intervention economically critical.
The joint health supplement market has grown to over $7 billion globally, driven by aging populations and growing awareness of natural alternatives to long-term NSAID use. Multi-ingredient formulas that address inflammation, cartilage repair, and joint lubrication simultaneously — like Joint Hero’s 7-ingredient blend — represent the latest evolution in this space.
Joint health follows a predictable but often overlooked trajectory. In your 20s and 30s, cartilage regeneration keeps pace with normal wear. By your 40s, regeneration starts to slow while degradation — driven by enzymes like ADAMTS-5 — continues at the same rate. By your 50s, the balance has tipped decisively toward degradation, which is why so many people experience their first significant joint problems in this decade. By 60, more than half of adults have X-ray evidence of osteoarthritis in at least one joint, even if symptoms haven’t fully manifested.
Understanding this timeline is critical because it highlights the importance of early intervention. By the time joint pain becomes a daily concern, significant cartilage loss has typically already occurred. This is why researchers emphasize that supporting cartilage health proactively — through anti-inflammatory nutrition, appropriate exercise, and targeted supplementation — can have a much greater impact than waiting until damage is advanced.
Over 30 billion doses of NSAIDs (ibuprofen, naproxen) are consumed annually in the United States. While effective for short-term pain relief, long-term NSAID use carries FDA-warned risks including gastrointestinal bleeding, kidney damage, and increased cardiovascular events. This has driven significant consumer migration toward natural alternatives that address inflammation without the same risk profile.
Multi-ingredient natural formulas that combine anti-inflammatory compounds (like boswellia serrata and turmeric) with cartilage-supporting nutrients (glucosamine, MSM) and joint lubricants (hyaluronic acid) represent the fastest-growing segment of the joint health market. Products like Joint Hero exemplify this comprehensive approach.